Silvia Menegatti
Suresnes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ablation of FAS confers allogeneic CD3- CAR T cells with resistance to rejection by T cells and natural killer cells.
Journal: Nature biomedical engineering
Published: February 05, 2024
In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4+ TH1 cell response.
In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4+ TH1 cell response.
Journal: Science immunology
Published: December 03, 2021
Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo.
Journal: Annals of the rheumatic diseases
Published: June 17, 2020
Methods to edit T cells for cancer immunotherapy.
Journal: Methods in enzymology
Published: January 18, 2020
Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.
Journal: Frontiers in immunology
Published: November 16, 2018
Expansion of Interleukin-22- and Granulocyte-Macrophage Colony-Stimulating Factor-Expressing, but Not Interleukin-17A-Expressing, Group 3 Innate Lymphoid Cells in the Inflamed Joints of Patients With Spondyloarthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 14, 2018
Brief Report: Interleukin-17 Blockade With Secukinumab in Peripheral Spondyloarthritis Impacts Synovial Immunopathology Without Compromising Systemic Immune Responses.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 30, 2017
IL-12 drives functional plasticity of human group 2 innate lymphoid cells.
Journal: The Journal of experimental medicine
Published: November 06, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026